Published on: May 05, 2020 at 09:30PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Dulaglutide 1.5Mg/0.5Ml Inj Pen
Sponsor:   Shanghai Zhongshan Hospital
Not yet recruiting
https://ift.tt/2YAvrac

0 Comments